AIM2 and COVID-19: In post-COVID patients with fibrosis, PBMCs show heightened responses to AIM2 ligand poly(deoxyadenylic-tymidylic) with increased pro-fibrotic cytokine production.381 Although host mtDNA is speculated to activate the AIM2 inflammasome in COVID-19,380 direct experimental evidence is absent.